Alnylam Pharmaceuticals
ALNY
#1143
Rank
S$26.44 B
Marketcap
S$197.45
Share price
1.54%
Change (1 day)
-65.68%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company